Company profile
Theragnostics Limited is a UK company with status active founded in 2013.
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
AA | Transaction MzQzNjk2NjA2MGFkaXF6a2N4
Published 24 Sep 2024 08:29
SH01 | Transaction MzQzNjg1NTg2N2FkaXF6a2N4
Published 23 Sep 2024 01:57
SH01 | Transaction MzQzMzY0MzYzMGFkaXF6a2N4 | Paper/PDF filed
Published 30 Aug 2024 12:21
Company registered at Companies House
1 Jun 2016 to 31 May 2018
Prostate cancer (PCa) is the most common cancer in men in the UK, accounting for 25% of all new cancer cases, with around 110 men diagnosed with PCa every day in the UK in 2011 (approximately 40k/year), and is the second most common cause of cancer related deaths. Currently, no commercial technology exists for the molecular imaging of PCa, however, there ...
